Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 338.95-157.4156.45-75.8944.49

What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES is 338.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025338.95
Mar2024-157.41
Mar202356.45
Mar2022-75.89
Mar202144.49

How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2025 338.95
Positive
Mar2024 -157.41
Negative
Mar2023 56.45
Positive
Mar2022 -75.89
Negative
Mar2021 44.49 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,095.7 Cr 1.3% -9.1% -7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

1.3%

-9.1%

-7.3%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses